Why is Godavari Drugs falling/rising?

As of 04-Jul, Godavari Drugs Ltd is currently priced at 91.00, showing no change (0.00%) from the previous trading session. The stock has underperformed its sector by 0.51% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 2.15%, and it has experienced a significant drop of 16.78% year-to-date. Additionally, the delivery volume has decreased by 35.55% compared to the 5-day average, indicating falling investor participation. While the company has an attractive valuation with a return on capital employed (ROCE) of 12.3 and is trading at a discount to its peers, its profits have fallen by 22.1% over the past year, contributing to the stock's negative performance.
In the broader market context, Godavari Drugs has underperformed the Sensex, which has gained 6.77% year-to-date, while Godavari Drugs has lost 16.78%. This trend of underperformance is reflected in the stock's returns over various periods, including a 12.16% decline over the past year. The company's weak long-term fundamental strength, characterized by a high debt-to-EBITDA ratio of 3.15 times and a significant drop in net sales, further exacerbates its challenges. Overall, the combination of declining profits, reduced investor interest, and poor performance relative to the benchmark suggests that Godavari Drugs is facing significant headwinds in the current market environment.